Diaglinis 35mg/500mg Syrup
Introduction of Diaglinis Syrup
Diaglinis 35mg/500mg Syrup is a combination medicine used in the treatment of fatty liver disease. It is a prescription medicine that works by improving the functioning of the liver.
Diaglinis 35mg/500mg Syrup is a combination of bile acid sequesterants and silymarin.
Diaglinis 35mg/500mg Syrup is a combination of bile acid sequesterants and silymarin.
Uses of Diaglinis Syrup
Benefits of Diaglinis Syrup
In Fatty liver disease
Fatty liver disease is a condition where there is an increased buildup of fat in the liver. This affects the functioning of the liver and makes you unhealthy. Diaglinis 35mg/500mg Syrup protects the liver from damage against harmful chemicals known as free radicals, thereby improving overall health of the liver. This helps the liver to perform its normal functions. To make the medicine more effective and for general health benefits, stop smoking, maintain a healthy weight, and do not drink too much alcohol.
Side effects of Diaglinis Syrup
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Diaglinis
- Dryness in mouth
- Drowsiness
How to use Diaglinis Syrup
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Diaglinis 35mg/500mg Syrup may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Diaglinis 35mg/500mg Syrup. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Diaglinis 35mg/500mg Syrup during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Diaglinis 35mg/500mg Syrup during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
Diaglinis 35mg/500mg Syrup may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Diaglinis 35mg/500mg Syrup in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Diaglinis 35mg/500mg Syrup in patients with liver disease. Please consult your doctor.
What if you forget to take Diaglinis Syrup?
If you miss a dose of Diaglinis 35mg/500mg Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Diaglinis Syrup
- Diaglinis 35mg/500mg Syrup is used for the treatment of fatty liver disease and helps in its proper functioning.
- Your doctor may monitor your liver function and bilirubin levels regularly.
- Avoid smoking and drinking as it further degrades liver functioning.
- Avoid fatty food, take a healthy diet, and exercise regularly.
- Keep sipping water or have sugar-free gum in order to relieve dryness in the mouth.
Fact Box
Habit Forming
No
Therapeutic Class
GASTRO INTESTINAL
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Drugs.com. Silymarin. [Accessed 12 Apr. 2019] (online) Available from:
- Petrie M, McKay G, Fisher M. Silymarin. Pracatical Diabetes. 2015;32(4):148-50. [Accessed 12 Apr. 2019] (online) Available from:
Marketer details
Name: AN Pharmaceuticals Pvt Ltd
Address: F1/4 Okhla Industrial Area, Phase1, Near Honda Show room, New Delhi - 110020
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present